Evidence map›Paper›PMID 34245586›Full record

ReviewJournal of the American Geriatrics Society2021

Participation of persons with dementia and their caregivers in research.

Lori Frank, Lee A Jennings, Ronald C Petersen, Tabassum Majid, Andrea Gilmore-Bykovskyi, Lonni Schicker, Jason Karlawish

Abstract readReview
In one paragraph

Review in Journal of the American Geriatrics Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Putting participants and study partners FIRST when clinical trials end early.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lori FrankRAND Corporation, Santa Monica, California, USA.ORCID 0000-0002-0023-7003
Lee A JenningsUniversity of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-9524-6921
Ronald C PetersenMayo Clinic, Rochester, Minnesota, USA.
Tabassum MajidPCORI, Washington, District of Columbia, USA.
Andrea Gilmore-BykovskyiUniversity of Wisconsin, Madison, Wisconsin, USA.
Lonni Schicker2020 Summit Steering Committee Member, USA.
Jason KarlawishPerelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Training Core (I)U54AG063546 · NIA · BROWN UNIVERSITY · PI Vincent Mor · 2019 to 2026
$125.9M
Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI CAREY E GLEASON · 2019 to 2026
$34.5M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Novel Approaches to Identifying and Engaging Disadvantaged Patients with Alzheimer’s Disease (AD) in Clinical ResearchK76AG060005 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI GILMORE-BYKOVSKYI, ANDREA L · 2018 to 2022
$1.1M
NIA NIH HHS K76 AG060005NIA NIH HHS K76AG060005NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG072979NIA NIH HHS U54 AG063546NIA NIH HHS U54AG063546
6 · The paper itself

Abstract

backgroundThe National Institute on Aging, in conjunction with the Department of Health and Human Services as part of the National Alzheimer's Project Act, convened a 2020 National Research Summit on Care, Services, and Supports for Persons with Dementia and their Caregivers. This review article addresses research participation by persons living with dementia (PLWD) and their care partners in two different ways: as research participants with input on outcomes studied and as engaged research partners.

resultsThis article summarizes each of the topics presented at this Summit session, followed by reflection from the session panelists. Lee Jennings examined collection of outcomes directly from PLWD and the potential for individualized outcomes to enhance measurement in intervention trials. Ron Petersen discussed the impact of nomenclature on research and clinical care, and how and why investigators should be mindful of the connection between dementia nomenclature and the conduct of dementia research. Tabassum Majid examined strategies for engagement in research, including specific examples of involving PLWD and their care partners (including staff in assisted living and skilled nursing facilities), and the potential for this research engagement to improve our understanding of interventions in dementia.

conclusionsResearch participation by PLWD and their care partners is evolving. This review summarizes three areas of opportunity and steps for researchers to work with PLWD and their care partners to design and conduct research that enhances knowledge based on what we learn from PLWD and their care partners, and creates knowledge with them.

Indexed as

CaregiversDementiaHealth Services for the AgedStakeholder ParticipationAgedAged, 80 and overFemaleHealth Services ResearchHumansMaleNational Institute on Aging (U.S.)Patient SelectionResearch DesignUnited Statesdementia nomenclaturegoal attainmentresearch engagement

Identifiers

PMID34245586
PMCPMC8369513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.